Brown S L, Charney D S, Woods S W, Heninger G R, Tallman J
Clinical Neuroscience Research Unit, Connecticut Mental Health Center, New Haven.
Psychopharmacology (Berl). 1988;94(1):24-8. doi: 10.1007/BF00735875.
Lymphocyte beta adrenergic receptor binding using [125I]CNP was determined in patients with panic disorder (N = 4) or agoraphobia with panic attacks (N = 17) and age- and sex-matched healthy subjects (N = 22). The patients showed a significantly lower number of beta-adrenergic receptor binding sites and a significantly higher affinity of binding than healthy subjects. A past or present history of major depression in the patients did not alter these findings. These results are consistent with a growing body of knowledge implicating noradrenergic dysfunction in the pathophysiology of panic anxiety.
采用[125I]CNP测定了恐慌症患者(N = 4)、伴有惊恐发作的广场恐惧症患者(N = 17)以及年龄和性别匹配的健康受试者(N = 22)的淋巴细胞β-肾上腺素能受体结合情况。与健康受试者相比,患者的β-肾上腺素能受体结合位点数量显著减少,结合亲和力显著增加。患者既往或目前的重度抑郁病史并未改变这些结果。这些结果与越来越多的证据一致,表明去甲肾上腺素能功能障碍与惊恐焦虑的病理生理学有关。